HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis

被引：0
作者：
Maria Bucova
Beata Majernikova
Vladimira Durmanova
Daniela Cudrakova
Karin Gmitterova
Iveta Lisa
Eleonora Klimova
Kristina Kluckova
Milan Buc
机构：
[1] Comenius University,Institute of Immunology, Faculty of Medicine
[2] Comenius University and University Hospital,1st. Department of Neurology, Faculty of Medicine
[3] Comenius University,2nd Department of Neurology, Faculty of Medicine
[4] Faculty Hospital of JA Raiman,Centre for Therapy and Diagnosis of Multiple Sclerosis
来源：
Neurological Sciences | 2020年 / 41卷
关键词：
HMGB1; Immunity; Inflammation; Multiple sclerosis; EDSS; MSSS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 604
页数：5
相关论文
共 50 条
[41]   Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients [J].
Tortosa-Carreres, Jordi ;
Cubas-Nunez, Laura ;
Quiroga-Varela, Ana ;
Castillo-Villalba, Jessica ;
Ramio-Torrenta, Lluis ;
Piqueras, Monica ;
Gasque-Rubio, Raquel ;
Quintanilla-Bordas, Carlos ;
Sanz, Maria Teresa ;
Lucas, Celia ;
Huertas-Pons, Joana Maria ;
Miguela, Albert ;
Casanova, Bonaventura ;
Laiz-Marro, Begona ;
Perez-Miralles, Francisco Carlos .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 88
[42]   Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease [J].
Vind, I ;
Johansen, JS ;
Price, PA ;
Munkholm, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) :599-605
[43]   Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases [J].
Singh, Harbinder ;
Agrawal, Devendra K. .
MOLECULES, 2022, 27 (21)
[44]   HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation [J].
Li, Jiamin ;
Wang, Zixin ;
Li, Jiameng ;
Zhao, Haiping ;
Ma, Qingfeng .
TRANSLATIONAL STROKE RESEARCH, 2025, 16 (03) :990-1015
[45]   HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury [J].
Hu, Xiaorong ;
Fu, Wenwen ;
Jiang, Hong .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (03) :489-489
[46]   Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study [J].
Hassan, Amr ;
Merghany, Nahla ;
Ouchkat, Fatima ;
Regragui, Wafa ;
Kedah, Hanaa ;
Hamdy, Sherif M. ;
Abdel-Naseer, Maged ;
Shehata, Hatem S. ;
Shalaby, Nevin M. ;
Kishk, Nirmeen A. ;
Nada, Mona A. F. ;
Hegazy, Mohamed, I ;
Farghaly, Marwa ;
Ahmed, Sandra M. ;
Hussein, Mona .
NUTRITIONAL NEUROSCIENCE, 2022, 25 (12) :2680-2689
[47]   HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease [J].
Andrassy, Martin ;
Volz, H. Christian ;
Schuessler, Alena ;
Gitsioudis, Gitsios ;
Hofmann, Nina ;
Laohachewin, Danai ;
Wienbrandt, Alexandra R. ;
Kaya, Ziya ;
Bierhaus, Angelika ;
Giannitsis, Evangelos ;
Katus, Hugo A. ;
Korosoglou, Grigorios .
PLOS ONE, 2012, 7 (12)
[48]   Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders [J].
Paudel, Yam Nath ;
Angelopoulou, Efthalia ;
Semple, Bridgette ;
Piperi, Christina ;
Othman, Iekhsan ;
Shaikh, Mohd Farooq .
ACS CHEMICAL NEUROSCIENCE, 2020, 11 (04) :485-500
[49]   Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta [J].
Batocchi, AP ;
Rotondi, M ;
Caggiula, M ;
Frisullo, G ;
Odoardi, F ;
Nociti, V ;
Carella, C ;
Tonali, PA ;
Mirabella, M .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 139 (1-2) :150-154
[50]   Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome [J].
Manganelli, Valeria ;
Capozzi, Antonella ;
Truglia, Simona ;
Alessandri, Cristiano ;
Lococo, Emanuela ;
Garofalo, Tina ;
De Carolis, Caterina ;
Conti, Fabrizio ;
Valesini, Guido ;
Sorice, Maurizio ;
Longo, Agostina ;
Misasi, Roberta .
JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
12345